Correction to: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and Clinical Practice Guidelines – Part 1: vitamins, minerals and nutritional supplements (Supportive Care in Cancer, (2019), 27, 10, (3997-4010), 10.1007/s00520-019-04887-x)

TY - JOUR

T1 - Correction to

T2 - Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and Clinical Practice Guidelines – Part 1: vitamins, minerals and nutritional supplements (Supportive Care in Cancer, (2019), 27, 10, (3997-4010), 10.1007/s00520-019-04887-x)

AU - Yarom, Noam

AU - Hovan, Allan

AU - Bossi, Paolo

AU - Ariyawardana, Anura

AU - Jensen, Siri Beier

AU - Gobbo, Margherita

AU - Saca-Hazboun, Hanan

AU - Kandwal, Abhishek

AU - Majorana, Alessandra

AU - Ottaviani, Giulia

AU - Pentenero, Monica

AU - Nasr, Narmin Mohammed

AU - Rouleau, Tanya

AU - Lucas, Anna Skripnik

AU - Treister, Nathaniel Simon

AU - Zur, Eyal

AU - Ranna, Vinisha

AU - Vaddi, Anusha

AU - Cheng, Karis Kin Fong

AU - Barasch, Andrei

AU - Lalla, Rajesh V.

AU - Elad, Sharon

AU - On behalf of The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO)

N1 - Publisher Copyright: © 2021, Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2021/7

Y1 - 2021/7

N2 - The original version of this paper contains a typographical error in the units: g/day was incorrectly written as mg/day. Specifically, on page 4005, paragraph 6: These studies demonstrated that glutamine at a dose range of 10–30 mg/day, delivered throughout the RT-CT, may be effective to prevent OM. it should read: These studies demonstrated that glutamine at a dose range of 10–30 g/day, delivered throughout the RT-CT, may be effective to prevent OM.

AB - The original version of this paper contains a typographical error in the units: g/day was incorrectly written as mg/day. Specifically, on page 4005, paragraph 6: These studies demonstrated that glutamine at a dose range of 10–30 mg/day, delivered throughout the RT-CT, may be effective to prevent OM. it should read: These studies demonstrated that glutamine at a dose range of 10–30 g/day, delivered throughout the RT-CT, may be effective to prevent OM.

UR - http://www.scopus.com/inward/record.url?scp=85103054952&partnerID=8YFLogxK

U2 - 10.1007/s00520-021-06141-9

DO - 10.1007/s00520-021-06141-9

M3 - Comment/debate/letter to the editor

C2 - 33761004

AN - SCOPUS:85103054952

SN - 0941-4355

VL - 29

SP - 4175

EP - 4176

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 7

ER -